tiprankstipranks
Trending News
More News >
Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H (SFOSF)
OTHER OTC:SFOSF
US Market

Shanghai Fosun Pharmaceutical (Group) Co (SFOSF) Ratios

Compare
22 Followers

Shanghai Fosun Pharmaceutical (Group) Co Ratios

SFOSF's free cash flow for Q1 2025 was ¥0.48. For the 2025 fiscal year, SFOSF's free cash flow was decreased by ¥ and operating cash flow was ¥0.18. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.06 1.00 1.06 1.04 1.01
Quick Ratio
0.85 0.78 0.85 0.85 0.80
Cash Ratio
0.49 0.41 0.49 0.35 0.40
Solvency Ratio
0.11 0.09 0.11 0.15 0.14
Operating Cash Flow Ratio
0.13 0.10 0.13 0.13 0.10
Short-Term Operating Cash Flow Coverage
0.35 0.23 0.35 0.42 0.33
Net Current Asset Value
¥ -17.78B¥ -23.06B¥ -17.78B¥ -14.49B¥ -12.62B
Leverage Ratios
Debt-to-Assets Ratio
0.28 0.27 0.28 0.26 0.29
Debt-to-Equity Ratio
0.68 0.66 0.68 0.62 0.65
Debt-to-Capital Ratio
0.40 0.40 0.40 0.38 0.39
Long-Term Debt-to-Capital Ratio
0.22 0.23 0.22 0.19 0.19
Financial Leverage Ratio
2.40 2.48 2.40 2.38 2.26
Debt Service Coverage Ratio
0.56 0.45 0.56 0.75 0.70
Interest Coverage Ratio
8.61 2.50 8.61 7.68 5.36
Debt to Market Cap
0.43 0.68 0.43 0.26 0.21
Interest Debt Per Share
11.96 11.79 11.96 9.81 9.72
Net Debt to EBITDA
1.78 2.20 1.78 1.60 2.04
Profitability Margins
Gross Profit Margin
47.28%47.54%47.28%48.14%55.68%
EBIT Margin
12.60%11.09%12.60%17.60%18.34%
EBITDA Margin
17.92%18.25%17.92%22.30%22.74%
Operating Profit Margin
18.88%7.99%18.88%16.19%15.58%
Pretax Profit Margin
10.41%7.89%10.41%15.52%15.43%
Net Profit Margin
8.49%5.76%8.49%12.12%12.09%
Continuous Operations Profit Margin
8.98%6.99%8.98%12.76%13.00%
Net Income Per EBT
81.56%73.10%81.56%78.11%78.30%
EBT Per EBIT
55.14%98.70%55.14%95.88%99.08%
Return on Assets (ROA)
3.48%2.10%3.48%5.07%4.38%
Return on Equity (ROE)
8.37%5.22%8.37%12.07%9.90%
Return on Capital Employed (ROCE)
11.23%4.15%11.23%9.87%8.03%
Return on Invested Capital (ROIC)
8.34%3.11%8.34%7.09%5.96%
Return on Tangible Assets
4.61%2.80%4.61%6.71%5.77%
Earnings Yield
6.48%5.78%6.48%6.61%4.59%
Efficiency Ratios
Receivables Turnover
5.38 4.90 5.38 6.03 5.58
Payables Turnover
3.69 3.53 3.69 3.99 4.08
Inventory Turnover
3.37 2.88 3.37 3.70 2.60
Fixed Asset Turnover
2.74 1.86 2.74 2.94 2.33
Asset Turnover
0.41 0.36 0.41 0.42 0.36
Working Capital Turnover Ratio
28.39 41.07 28.39 58.78 19.05
Cash Conversion Cycle
77.29 97.72 77.29 67.95 116.39
Days of Sales Outstanding
67.86 74.56 67.86 60.58 65.47
Days of Inventory Outstanding
108.42 126.69 108.42 98.74 140.30
Days of Payables Outstanding
98.99 103.53 98.99 91.37 89.38
Operating Cycle
176.29 201.25 176.29 159.32 205.77
Cash Flow Ratios
Operating Cash Flow Per Share
1.62 1.27 1.62 1.54 1.01
Free Cash Flow Per Share
-0.64 -0.72 -0.64 -0.40 -0.73
CapEx Per Share
2.26 1.99 2.26 1.95 1.73
Free Cash Flow to Operating Cash Flow
-0.40 -0.56 -0.40 -0.26 -0.72
Dividend Paid and CapEx Coverage Ratio
0.51 0.44 0.51 0.57 0.41
Capital Expenditure Coverage Ratio
0.72 0.64 0.72 0.79 0.58
Operating Cash Flow Coverage Ratio
0.14 0.11 0.14 0.16 0.11
Operating Cash Flow to Sales Ratio
0.10 0.08 0.10 0.10 0.09
Free Cash Flow Yield
-2.90%-4.65%-2.90%-1.43%-2.33%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
15.44 17.31 15.44 15.12 21.80
Price-to-Sales (P/S) Ratio
1.31 1.00 1.31 1.83 2.63
Price-to-Book (P/B) Ratio
1.29 0.90 1.29 1.82 2.16
Price-to-Free Cash Flow (P/FCF) Ratio
-34.46 -21.48 -34.46 -69.84 -42.99
Price-to-Operating Cash Flow Ratio
13.66 12.10 13.66 18.11 30.95
Price-to-Earnings Growth (PEG) Ratio
-0.68 -0.46 -0.68 0.51 2.18
Price-to-Fair Value
1.29 0.90 1.29 1.82 2.16
Enterprise Value Multiple
9.09 7.66 9.09 9.82 13.62
Enterprise Value
71.60B 57.89B 71.60B 85.44B 93.89B
EV to EBITDA
9.09 7.66 9.09 9.82 13.62
EV to Sales
1.63 1.40 1.63 2.19 3.10
EV to Free Cash Flow
-42.84 -30.11 -42.84 -83.45 -50.55
EV to Operating Cash Flow
16.98 16.96 16.98 21.64 36.40
Tangible Book Value Per Share
10.67 10.59 10.67 9.99 10.08
Shareholders’ Equity Per Share
17.09 17.04 17.09 15.33 14.44
Tax and Other Ratios
Effective Tax Rate
0.14 0.11 0.14 0.18 0.16
Revenue Per Share
16.85 15.44 16.85 15.26 11.83
Net Income Per Share
1.43 0.89 1.43 1.85 1.43
Tax Burden
0.82 0.73 0.82 0.78 0.78
Interest Burden
0.83 0.71 0.83 0.88 0.84
Research & Development to Revenue
0.10 0.11 0.10 0.10 0.09
SG&A to Revenue
0.02 0.11 0.02 0.02 0.03
Stock-Based Compensation to Revenue
<0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
1.07 1.43 1.07 0.79 0.65
Currency in CNY
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis